Search

Letoripe

Letoripe

letrozole

Manufacturer:

Ambica

Distributor:

Zuellig

Marketer:

Multicare
NEW Brand Resources
Concise Prescribing Info
Contents
Letrozole
Indications/Uses
Advanced breast cancer in postmenopausal women w/ disease progression following antiestrogen therapy.
Click to view Letoripe detailed prescribing information
Dosage/Direction for Use
Adult & elderly 2.5 mg once daily.
Click to view Letoripe detailed prescribing information
Overdosage
View Letoripe overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity.
Click to view Letoripe detailed prescribing information
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Letoripe detailed prescribing information
Special Precautions
Severe hepatic impairment. Pregnancy & lactation. Childn.
Click to view Letoripe detailed prescribing information
Adverse Reactions
Progression of tumor, thromboembolic events, vag bleeding.
Click to view Letoripe detailed prescribing information
Storage
View Letoripe storage conditions for details to ensure optimal shelf-life.
Description
View Letoripe description for details of the chemical structure and excipients (inactive components).
Action
View Letoripe mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BG04 - letrozole ; Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.
Presentation/Packing
Form
Letoripe tab 2.5 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in